Olfactory and Neuropsychological Functioning in Olfactory Reference Syndrome.


Journal

Psychosomatics
ISSN: 1545-7206
Titre abrégé: Psychosomatics
Pays: England
ID NLM: 0376506

Informations de publication

Date de publication:
Historique:
received: 08 07 2019
revised: 20 12 2019
accepted: 23 12 2019
pubmed: 29 2 2020
medline: 27 4 2021
entrez: 29 2 2020
Statut: ppublish

Résumé

Olfactory reference syndrome (ORS) is an underrecognized, understudied, and often severe psychiatric disorder characterized by a prominent and distressing or impairing preoccupation with a false belief of emitting an offensive body odor. As this condition has only recently been recognized in the International Classification of Diseases (the 11th Edition), no empirical evidence exists about the underlying features and etiology of the disorder. To examine the neuropsychological and olfactory functioning of individuals with ORS and address whether there is central nervous system or sensory dysfunction associated with the condition. In this preliminary investigation, 9 consecutive participants with ORS completed a structured clinical interview and neuropsychological and olfaction evaluations. A proportion of individuals with ORS displayed deficits in aspects of cognitive functioning (i.e., processing speed, executive functioning, recognition memory bias for ORS-related words), olfaction functioning (i.e., odor detection and discrimination), and emotional processing. Based on these preliminary findings of cognitive, olfaction, and emotional processing deficits in individuals with ORS, further neuropsychological and olfaction studies are needed that better characterize this understudied patient group and address this study's limitations.

Sections du résumé

BACKGROUND
Olfactory reference syndrome (ORS) is an underrecognized, understudied, and often severe psychiatric disorder characterized by a prominent and distressing or impairing preoccupation with a false belief of emitting an offensive body odor. As this condition has only recently been recognized in the International Classification of Diseases (the 11th Edition), no empirical evidence exists about the underlying features and etiology of the disorder.
OBJECTIVE
To examine the neuropsychological and olfactory functioning of individuals with ORS and address whether there is central nervous system or sensory dysfunction associated with the condition.
METHODS
In this preliminary investigation, 9 consecutive participants with ORS completed a structured clinical interview and neuropsychological and olfaction evaluations.
RESULTS
A proportion of individuals with ORS displayed deficits in aspects of cognitive functioning (i.e., processing speed, executive functioning, recognition memory bias for ORS-related words), olfaction functioning (i.e., odor detection and discrimination), and emotional processing.
CONCLUSIONS
Based on these preliminary findings of cognitive, olfaction, and emotional processing deficits in individuals with ORS, further neuropsychological and olfaction studies are needed that better characterize this understudied patient group and address this study's limitations.

Identifiants

pubmed: 32107040
pii: S0033-3182(19)30266-X
doi: 10.1016/j.psym.2019.12.009
pmc: PMC7211111
mid: NIHMS1548378
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

261-267

Subventions

Organisme : NIMH NIH HHS
ID : K24 MH063975
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

Psychiatr Danub. 2009 Jun;21(2):166-73
pubmed: 19556944
Q J Exp Psychol A. 1988 Nov;40(4):801-12
pubmed: 3212213
J Anxiety Disord. 2002;16(3):289-98
pubmed: 12214814
Depress Anxiety. 2010 Jun;27(6):592-9
pubmed: 20533369
Psychiatry Res. 2010 Apr 30;176(2-3):183-9
pubmed: 20138370
Gen Hosp Psychiatry. 2006 Mar-Apr;28(2):174-7
pubmed: 16516069
Am J Psychiatry. 1998 Jan;155(1):102-8
pubmed: 9433346
J Psychiatr Res. 2004 Mar-Apr;38(2):201-6
pubmed: 14757335
Prog Neuropsychopharmacol Biol Psychiatry. 2015 Apr 3;58:81-8
pubmed: 25545410
Chem Senses. 1997 Feb;22(1):39-52
pubmed: 9056084
Psychiatr Clin North Am. 2003 Mar;26(1):25-40
pubmed: 12683258
Gen Hosp Psychiatry. 2011 Jul-Aug;33(4):398-406
pubmed: 21762838
CNS Spectr. 2017 Feb;22(1):51-60
pubmed: 27899165
Nord J Psychiatry. 2015 Aug;69(6):444-52
pubmed: 25613319
Acta Psychiatr Scand. 1971;47(4):484-509
pubmed: 5146719
R Soc Open Sci. 2017 May 31;4(5):160855
pubmed: 28572987
Int J Psychophysiol. 2007 Sep;65(3):177-81
pubmed: 17434636
Neurosci Biobehav Rev. 2008 Sep;32(7):1315-25
pubmed: 18555528
Psychol Med. 2013 May;43(5):1109-17
pubmed: 23171833
Front Neurosci. 2014 Sep 11;8:289
pubmed: 25309312

Auteurs

Channing Sofko (C)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI; Department of Psychiatry, Rhode Island Hospital, Providence, RI; Department of Psychiatry, The Miriam Hospital, Providence, RI; Division of Mental Health and Behavioral Sciences, Bay Pines Veterans Affairs Health Care System, Bay Pines, Florida. Electronic address: channing.sofko@gmail.com.

Geoffrey Tremont (G)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI; Department of Psychiatry, Rhode Island Hospital, Providence, RI.

Jing Ee Tan (JE)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI; Department of Psychiatry, Rhode Island Hospital, Providence, RI; Division of Neurology, The University of British Columbia, Vancouver, British Columbia, Canada.

Holly Westervelt (H)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI; Department of Psychiatry, Rhode Island Hospital, Providence, RI; Department of Neurology, Vanderbilt University Medical Center, Nashville, TN.

David C Ahern (DC)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI; Department of Psychiatry, The Miriam Hospital, Providence, RI.

William Menard (W)

Department of Psychiatry, Rhode Island Hospital, Providence, RI; Department of Neurology, Butler Hospital, Providence, RI.

Katharine A Phillips (KA)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI; Department of Psychiatry, Rhode Island Hospital, Providence, RI; Department of Psychiatry, Weill Cornell Medical College, New York, NY; Department of Psychiatry, New York-Presbyterian Hospital, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH